×

img Accessibility Controls

Technologies Banner

All Technologies

Candidate Drug 80/5Technology Demonstration4 (Anti-dyslipidemic)

Project Overview

Anti-Dyslipidemic drug especially used in Dyslipidemia of Diabetes, Metabolic syndrome Obesity For managing patients of hyperlipidemia especially triglycerides and cholesterol

Benefits

The compound inhibits the biosynthesis of cholesterol and reduces the rate of cholesterol turnover. It also stimulates the LDL receptor binding activity and thereby increasing the catabolism of LDL cholesterol and significantly reduces the lipid peroxidation. It has a Triglyceride lowering activity als which is the main Lipid abnormality found in Indian population.

Source

Quick Information
Thrust Areas
Pharmaceutical Sciences
Focus Area
Hyperlipidemia Treatment
Source Title
Output
TRL: Technology Readiness Level
Technology Demonstration
Patent
EP1020191, IN193304, US65Technology Demonstration9862, US68Technology Demonstration5Technology Demonstration58
arrowtop
Latest Updates
Loading…